Role of p38 mitogen-activated protein kinase isoforms in murine skin inflammation induced by 12-O-tetradecanoylphorbol 13-acetate

Acta Dermato-Venereologica

Volumn 91, Issue 3, 2011, Pages 271-278

  Langer Lilleholt, Louise ^a   Johansen, Claus ^a   Arthur, J Simon C ^b   Funding, Anne ^a   Bibby, Bo Martin ^c   Kragballe, Knud ^a   Iversen, Lars ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b UNIVERSITY OF DUNDEE   (United Kingdom)

^c AARHUS UNIVERSITY   (Denmark)

Author keywords

Infammation; Knockout mice; P38 MAPK; TPA

Indexed keywords

4 O METHYLPHORBOL 13 ACETATE 12 MYRISTATE; INTERLEUKIN 1BETA; INTERLEUKIN 6; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE P38; MITOGEN ACTIVATED PROTEIN KINASE P38 INHIBITOR; MYELOPEROXIDASE; SB202190; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL INFILTRATION; CONTROLLED STUDY; EAR; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; INFLAMMATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SKIN INFLAMMATION;

ANIMALS; DERMATITIS; DISEASE MODELS, ANIMAL; ENZYME ACTIVATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE EXPRESSION REGULATION; IMIDAZOLES; INFLAMMATION MEDIATORS; INTERLEUKIN-1BETA; INTERLEUKIN-6; ISOENZYMES; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MITOGEN-ACTIVATED PROTEIN KINASE 11; MITOGEN-ACTIVATED PROTEIN KINASE 13; MITOGEN-ACTIVATED PROTEIN KINASE 14; PROTEIN KINASE INHIBITORS; PYRIDINES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SKIN; TETRADECANOYLPHORBOL ACETATE; TIME FACTORS;

EID: 79955738020     PISSN: 00015555     EISSN: None     Source Type: Journal    
DOI: 10.2340/00015555-1046     Document Type: Article

References (32)

1. Ashwell JD. The many paths to p38 mitogen-activated protein kinase activation in the immune system. Nat Rev Immunol 2006; 6: 532-540.
2. Roux PP, Blenis J. ERK and p38 MAPK-activated protein kinases: a family of protein kinases with diverse biological functions. Microbiol Mol Biol Rev 2004; 68: 320-344.
3. Ono K, Han J. The p38 signal transduction pathway: activation and function. Cell Signal 2000; 12: 1-13.
4. Zarubin T, Han J. Activation and signaling of the p38 MAP kinase pathway. Cell Res 2005; 15: 11-18.
5. Kyriakis JM, Avruch J. Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and infammation. Physiol Rev 2001; 81: 807-869.
6. Hale KK, Trollinger D, Rihanek M, Manthey CL. Differential expression and activation of p38 mitogen-activated protein kinase alpha, beta, gamma, and delta in infamma-tory cell lineages. J Immunol 1999; 162: 4246-4252.
7. Jiang y, Chen C, Li Z, guo W, gegner JA, Lin S, et al. Characterization of the structure and function of a new mitogen-activated protein kinase (p38beta). J Biol Chem 1996; 271: 17920-17926.
8. Kumar S, McDonnell PC, gum RJ, Hand AT, Lee JC, young PR. Novel homologues of CSBP/p38 MAP kinase: activation, substrate specifcity and sensitivity to inhibition by pyridinyl imidazoles. Biochem Biophys Res Commun 1997; 235: 533-538.
9. Li Z, Jiang Y, Ulevitch RJ, Han J. The primary structure of p38 gamma: a new member of p38 group of MAP kinases. Biochem Biophys Res Commun 1996; 228: 334-340.
10. Funding AT, Johansen C, Kragballe K, Otkjaer K, Jensen UB, Madsen MW, et al. Mitogen- and stress-activated protein kinase 1 is activated in lesional psoriatic epidermis and regulates the expression of pro-infammatory cytokines. J Invest Dermatol 2006; 126: 1784-1791.
11. Funding AT, Johansen C, gaestel M, Bibby BM, Lilleholt LL, Kragballe K, et al. Reduced oxazolone-induced skin infammation in MAPKAP kinase 2 knockout mice. J Invest Dermatol 2009; 129: 891-898.
12. Johansen C, Kragballe K, Westergaard M, Henningsen J, Kristiansen K, Iversen L. The mitogen-activated protein kinases p38 and ERK1/2 are increased in lesional psoriatic skin. Br J Dermatol 2005; 152: 37-42.
13. Johansen C, Funding AT, Otkjaer K, Kragballe K, Jensen UB, Madsen M, et al. Protein expression of TNF-alpha in psoriatic skin is regulated at a posttranscriptional level by MAPK-activated protein kinase 2. J Immunol 2006; 176: 1431-1438.
14. Takanami-Ohnishi y, Amano S, Kimura S, Asada S, Utani A, Maruyama M, et al. Essential role of p38 mitogen-activated protein kinase in contact hypersensitivity. J Biol Chem 2002; 277: 37896-37903.
15. Ipaktchi K, Mattar A, Niederbichler AD, Hoesel LM, Hemmila MR, Su GL, et al. Topical p38MAPK inhibition reduces dermal infammation and epithelial apoptosis in burn wounds. Shock 2006; 26: 201-209.
16. Dashti SR, Efmova T, Eckert RL. MEK7-dependent activation of p38 MAP kinase in keratinocytes. J Biol Chem 2001; 276: 8059-8063.
17. Eckert RL, Efmova T, Balasubramanian S, Crish JF, Bone F, Dashti S. p38 Mitogen-activated protein kinases on the body surface - a function for p38 delta. J Invest Dermatol 2003; 120: 823-828.
18. Karaman MW, Herrgard S, Treiber DK, gallant P, Atteridge CE, Campbell BT, et al. A quantitative analysis of kinase inhibitor selectivity. Nat Biotechnol 2008; 26: 127-132.
19. Adams RH, Porras A, Alonso G, Jones M, Vintersten K, Panelli S, et al. Essential role of p38alpha MAP kinase in placental but not embryonic cardiovascular development. Mol Cell 2000; 6: 109-116.
20. Allen M, Svensson L, Roach M, Hambor J, McNeish J, Gabel CA. Defciency of the stress kinase p38alpha results in embryonic lethality: characterization of the kinase dependence of stress responses of enzyme-defcient embryonic stem cells. J Exp Med 2000; 191: 859-870.
21. Mudgett JS, Ding J, guh-Siesel L, Chartrain NA, yang L, gopal S, et al. Essential role for p38alpha mitogen-activated protein kinase in placental angiogenesis. Proc Natl Acad Sci USA 2000; 97: 10454-10459.
22. Kim C, Sano Y, Todorova K, Carlson BA, Arpa L, Celada A, et al. The kinase p38 alpha serves cell type-specifc infammatory functions in skin injury and coordinates pro- and anti-infammatory gene expression. Nat Immunol 2008; 9: 1019-1027.
23. O'Keefe SJ, Mudgett JS, Cupo S, Parsons JN, Chartrain NA, Fitzgerald C, et al. Chemical genetics defne the roles of p38alpha and p38beta in acute and chronic infammation. J Biol Chem 2007; 282: 34663-34671.
24. Beardmore VA, Hinton HJ, Eftychi C, Apostolaki M, Armaka M, Darragh J, et al. generation and characterization of p38beta (MAPK11) gene-targeted mice. Mol Cell Biol 2005; 25: 10454-10464.
25. Sabio G, Arthur JS, Kuma Y, Peggie M, Carr J, Murray-Tait V, et al. p38gamma regulates the localisation of SAP97 in the cytoskeleton by modulating its interaction with gKAP. EMBO J 2005; 24: 1134-1145.
26. Bradley PP, Priebat DA, Christensen RD, Rothstein G. Measurement of cutaneous infammation: estimation of neutrophil content with an enzyme marker. J Invest Der-matol 1982; 78: 206-209.
27. Otkjaer K, Kragballe K, Funding AT, Clausen JT, Noerby PL, Steiniche T, et al. The dynamics of gene expression of interleukin-19 and interleukin-20 and their receptors in psoriasis. Br J Dermatol 2005; 153: 911-918.
28. Schindler EM, Hindes A, gribben EL, Burns CJ, Yin Y, Lin MH, et al. p38delta mitogen-activated protein kinase is essential for skin tumor development in mice. Cancer Res 2009; 69: 4648-4655.
29. gudjonsson JE, Johnston A, Dyson M, Valdimarsson H, Elder JT. Mouse models of psoriasis. J Invest Dermatol 2007; 127: 1292-1308.
30. Kwong J, Hong L, Liao R, Deng Q, Han J, Sun P. p38alpha and p38gamma mediate oncogenic ras-induced senescence through differential mechanisms. J Biol Chem 2009; 284: 11237-11246.
31. Askari N, Diskin R, Avitzour M, Capone R, Livnah O, Engelberg D. Hyperactive variants of p38alpha induce, whereas hyperactive variants of p38gamma suppress, activating protein 1-mediated transcription. J Biol Chem 2007; 282: 91-99.
32. Ananieva O, Darragh J, Johansen C, Carr JM, McIlrath J, Park JM, et al. The kinases MSK1 and MSK2 act as negative regulators of Toll-like receptor signaling. Nat Immunol 2008; 9: 1028-1036.